Clinical evaluation of human chorionic gonadotropin levels in men with testicular tumors

J. S. Cochran, P. C. Walsh, J. C. Porter

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

In patients with testicular tumor, HCG β serves as a sensitive, specific marker of tumor activity. Because HCG β levels correlate well with response to therapy, this test may be useful in selecting men for adjunctive irradiation or chemotherapy. HCG β is far more sensitive and specific than conventional methods for detecting HCG production. Following unilateral orchiectomy for carcinoma of the testis, elevated serum luteinizing hormone levels are common, and may be unrelated to the presence or activity of residual tumor. In this study, 25% of patients with testicular tumors had demonstrable HCG β levels. This test should provide a reliable index for following disease activity and response to therapy.

Original languageEnglish (US)
Pages (from-to)542-543
Number of pages2
JournalSurgical Forum
VolumeVol. 25
StatePublished - 1974

Fingerprint

Testicular Neoplasms
Chorionic Gonadotropin
Orchiectomy
Residual Neoplasm
Tumor Biomarkers
Luteinizing Hormone
Testis
Carcinoma
Drug Therapy
Therapeutics
Serum

ASJC Scopus subject areas

  • Surgery

Cite this

Cochran, J. S., Walsh, P. C., & Porter, J. C. (1974). Clinical evaluation of human chorionic gonadotropin levels in men with testicular tumors. Surgical Forum, Vol. 25, 542-543.

Clinical evaluation of human chorionic gonadotropin levels in men with testicular tumors. / Cochran, J. S.; Walsh, P. C.; Porter, J. C.

In: Surgical Forum, Vol. Vol. 25, 1974, p. 542-543.

Research output: Contribution to journalArticle

Cochran, JS, Walsh, PC & Porter, JC 1974, 'Clinical evaluation of human chorionic gonadotropin levels in men with testicular tumors', Surgical Forum, vol. Vol. 25, pp. 542-543.
Cochran, J. S. ; Walsh, P. C. ; Porter, J. C. / Clinical evaluation of human chorionic gonadotropin levels in men with testicular tumors. In: Surgical Forum. 1974 ; Vol. Vol. 25. pp. 542-543.
@article{49bcc3118ba742828b13376a91f48907,
title = "Clinical evaluation of human chorionic gonadotropin levels in men with testicular tumors",
abstract = "In patients with testicular tumor, HCG β serves as a sensitive, specific marker of tumor activity. Because HCG β levels correlate well with response to therapy, this test may be useful in selecting men for adjunctive irradiation or chemotherapy. HCG β is far more sensitive and specific than conventional methods for detecting HCG production. Following unilateral orchiectomy for carcinoma of the testis, elevated serum luteinizing hormone levels are common, and may be unrelated to the presence or activity of residual tumor. In this study, 25{\%} of patients with testicular tumors had demonstrable HCG β levels. This test should provide a reliable index for following disease activity and response to therapy.",
author = "Cochran, {J. S.} and Walsh, {P. C.} and Porter, {J. C.}",
year = "1974",
language = "English (US)",
volume = "Vol. 25",
pages = "542--543",
journal = "Surgical Forum",
issn = "0071-8041",
publisher = "American College of Surgeons",

}

TY - JOUR

T1 - Clinical evaluation of human chorionic gonadotropin levels in men with testicular tumors

AU - Cochran, J. S.

AU - Walsh, P. C.

AU - Porter, J. C.

PY - 1974

Y1 - 1974

N2 - In patients with testicular tumor, HCG β serves as a sensitive, specific marker of tumor activity. Because HCG β levels correlate well with response to therapy, this test may be useful in selecting men for adjunctive irradiation or chemotherapy. HCG β is far more sensitive and specific than conventional methods for detecting HCG production. Following unilateral orchiectomy for carcinoma of the testis, elevated serum luteinizing hormone levels are common, and may be unrelated to the presence or activity of residual tumor. In this study, 25% of patients with testicular tumors had demonstrable HCG β levels. This test should provide a reliable index for following disease activity and response to therapy.

AB - In patients with testicular tumor, HCG β serves as a sensitive, specific marker of tumor activity. Because HCG β levels correlate well with response to therapy, this test may be useful in selecting men for adjunctive irradiation or chemotherapy. HCG β is far more sensitive and specific than conventional methods for detecting HCG production. Following unilateral orchiectomy for carcinoma of the testis, elevated serum luteinizing hormone levels are common, and may be unrelated to the presence or activity of residual tumor. In this study, 25% of patients with testicular tumors had demonstrable HCG β levels. This test should provide a reliable index for following disease activity and response to therapy.

UR - http://www.scopus.com/inward/record.url?scp=0016164099&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016164099&partnerID=8YFLogxK

M3 - Article

C2 - 4474717

AN - SCOPUS:0016164099

VL - Vol. 25

SP - 542

EP - 543

JO - Surgical Forum

JF - Surgical Forum

SN - 0071-8041

ER -